FDG PET-CT: Need for vigilance in patients treated with bleomycin

Anna N Paschali, Gopinath Gnanasegaran, Gary J Cook

Indian Journal of Nuclear Medicine 2017 32(2):122-124

Bleomycin-induced interstitial lung disease is not a rare complication of treatment and may prove to be fatal if not suspected early in its course. As FDG PET-CT has become an essential clinical tool for interim and end-of-treatment response assessment in oncology, it is important that radiologists/nuclear medicine specialists be aware of the features of this potentially treatable condition so that treatment can be instigated during an early reversible phase before pulmonary damage has occurred. Herein, we report two cases of bleomycin toxicity featuring different patterns on the treatment-response assessment FDG PET-CT scan.

http://ift.tt/2mUW1Yk